{"id":740,"date":"2017-03-31T15:26:09","date_gmt":"2017-03-31T12:26:09","guid":{"rendered":"https:\/\/infeksiyon.org\/?p=740"},"modified":"2017-03-31T15:44:13","modified_gmt":"2017-03-31T12:44:13","slug":"diklofenak-ve-ibuprofen-kardiyak-arrest-riski-onemli-olcude-artti","status":"publish","type":"post","link":"https:\/\/infeksiyon.org\/en\/diklofenak-ve-ibuprofen-kardiyak-arrest-riski-onemli-olcude-artti\/","title":{"rendered":"Diclofenac and ibuprofen linked to significantly increased risk of cardiac arrest"},"content":{"rendered":"<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9780\" new=\"\" roman=\"\" style=\"box-sizing:border-box;color:rgb(84,84,84);font-family:minion-pro,TimesNewRoman,\" times=\"\">\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9781\" style=\"box-sizing:border-box;float:none\">\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9782\" style=\"box-sizing:border-box\">\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9783\" style=\"box-sizing: border-box; border: medium none; margin-bottom: 27px; font-size: 2.4em; line-height: 1.375; font-family: myriad-pro,Helvetica,Arial,sans-serif; text-align: justify;\">\n\t\t\t\tHaving studied data from nearly 30,000 patients with a history of cardiac arrest, researchers conclude that over-the-counter NSAIDs should only be available in pharmacies and at low doses and quantities.\n\t\t\t<\/div>\n<div style=\"box-sizing: border-box; border: medium none; margin-bottom: 27px; font-size: 2.4em; line-height: 1.375; font-family: myriad-pro,Helvetica,Arial,sans-serif; text-align: justify;\">\n\t\t\t\t<span ar1sisgppiafwutvjkumn88hojnkcf-3obgmmalvb2d8pftb-5rbohddqyqwszumw7lq-atkkmrbezjj_1t-v-p9dqykxajsuiag378=\"s0-d-e1-ft#http:\/\/\/magazine\/graphics\/decoration\/generic.border.png\"><a data-saferedirecturl=\"https:\/\/www.google.com\/url?hl=tr&amp;q=http:\/\/www.pharmaceutical-journal.com\/CP-April-2017,-Vol-9,-No-4\/1024.issue&amp;source=gmail&amp;ust=1491028733470000&amp;usg=AFQjCNGORRowy2zq6x530FZ7ivG5-FjrSg\" href=\"http:\/\/www.pharmaceutical-journal.com\/CP-April-2017,-Vol-9,-No-4\/1024.issue\" id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9778\" style=\"box-sizing:border-box;color:rgb(0,83,133);text-decoration:none\" target=\"_blank\">Clinical Pharmacist<\/a><\/span><span id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9779\" style=\"box-sizing:border-box;margin-right:0px;background:none right center no-repeat;padding-right:0px\">29 MAR 2017<\/span>\n\t\t\t<\/div>\n<\/p><\/div>\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9784\" style=\"box-sizing:border-box\">\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9785\" style=\"box-sizing:border-box;margin:0px auto 9px;padding:8px;border:1px solid rgb(212,212,212);background-color:rgb(246,246,246);clear:both;overflow:visible\">\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9786\" style=\"box-sizing: border-box; border: medium none; font-size: 1.6em; line-height: 1.125; text-align: justify;\">\n\t\t\t\t\t&nbsp;\n\t\t\t\t<\/div>\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9788\" style=\"box-sizing: border-box; border: medium none; margin-top: 9px; margin-bottom: 9px; font-size: 1.4em; line-height: 1.286; color: rgb(135, 135, 135); font-family: myriad-pro,Helvetica,Arial,sans-serif; text-align: justify;\">\n\t\t\t\t\t<cite id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9789\" style=\"box-sizing:border-box;font-style:normal\">Source: Stephen Barnes \/ Alamy Stock Photo<\/cite>\n\t\t\t\t<\/div>\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9790\" style=\"box-sizing: border-box; border: medium none; margin-top: 9px; margin-bottom: 9px; font-size: 1.4em; line-height: 1.286; color: rgb(135, 135, 135); font-family: myriad-pro,Helvetica,Arial,sans-serif; text-align: justify;\">\n\t\t\t\t\tResearch published in the&nbsp;<em id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9791\" style=\"box-sizing:border-box\">European Heart Journal: Cardiovascular Pharmacotherapy<\/em>&nbsp;showed that diclofenac was linked to a 50% increased risk of cardiac arrest while ibuprofen was linked to a 31% increase in risk.\n\t\t\t\t<\/div>\n<\/p><\/div>\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9792\" style=\"box-sizing: border-box; border: medium none; margin-bottom: 27px; font-size: 2em; line-height: 1.35; text-align: justify;\">\n\t\t\t\tNon-steroidal anti-inflammatory drugs (NSAIDs) have been associated with increased cardiovascular risk for the past ten years, but the link between NSAIDs and cardiac arrest specifically has not been examined.\n\t\t\t<\/div>\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9793\" style=\"box-sizing: border-box; border: medium none; margin-bottom: 27px; font-size: 2em; line-height: 1.35; text-align: justify;\">\n\t\t\t\tTo investigate, researchers used the Danish Cardiac Arrest Registry to identify 28,947 patients who had had an out-of-hospital cardiac arrest between 2001 and 2010. The data showed that 3,376 were treated with an NSAID up to 30 days before their cardiac arrest.\n\t\t\t<\/div>\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9794\" style=\"box-sizing: border-box; border: medium none; margin-bottom: 27px; font-size: 2em; line-height: 1.35; text-align: justify;\">\n\t\t\t\tThe results, published in the&nbsp;<em id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9795\" style=\"box-sizing:border-box\">European Heart Journal: Cardiovascular Pharmacotherapy<\/em><sup id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9796\" style=\"box-sizing:border-box\"><a data-saferedirecturl=\"https:\/\/www.google.com\/url?hl=tr&amp;q=http:\/\/www.pharmaceutical-journal.com\/news-and-analysis\/research-briefing\/diclofenac-and-ibuprofen-linked-to-significantly-increased-risk-of-cardiac-arrest\/20202466.article%23fn_1&amp;source=gmail&amp;ust=1491028733470000&amp;usg=AFQjCNFSC3jNZ8My67X2qQqXq-LkyQnPog\" href=\"http:\/\/www.pharmaceutical-journal.com\/news-and-analysis\/research-briefing\/diclofenac-and-ibuprofen-linked-to-significantly-increased-risk-of-cardiac-arrest\/20202466.article#fn_1\" id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9797\" style=\"box-sizing:border-box;color:rgb(0,83,133);text-decoration:none\" target=\"_blank\" title=\"Sondergaard K, Weeke P, Wissenberg M et al. Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Eur Heart J Cardiovasc Pharmacother 2017;356:100-107. doi: 10.1093\/ehjcvp\/pvw041\">[1]<\/a><\/sup>&nbsp;(2017;356:<wbr \/>100-107), also showed that the NSAID diclofenac was linked to a 50% increased risk of cardiac arrest (odds ratio [OR] 1.50, 95% confidence interval [CI] 1.23&shy;&ndash;1.82) while ibuprofen was linked to a 31% increase in risk (OR 1.31, 95% CI 1.14&ndash;1.51).\n\t\t\t<\/div>\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9798\" style=\"box-sizing: border-box; border: medium none; margin-bottom: 27px; font-size: 2em; line-height: 1.35; text-align: justify;\">\n\t\t\t\tThe researchers say that any conclusions on causality should be made with caution but recommend that over-the-counter NSAIDs should only be available at pharmacies, in limited quantities and at low doses.\n\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<h3 id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9799\" style=\"box-sizing: border-box; border: medium none; margin-top: 0px; margin-bottom: 12px; font-family: myriad-pro,Helvetica,Arial,sans-serif; font-weight: 400; font-size: 2.1em; line-height: 1.286; text-align: justify;\">\n\tReferences:<br \/>\n<\/h3>\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9800\" new=\"\" roman=\"\" style=\"box-sizing:border-box;color:rgb(84,84,84);font-family:minion-pro,TimesNewRoman,\" times=\"\">\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9801\" style=\"box-sizing:border-box;float:none\">\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9802\" style=\"box-sizing:border-box\">\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9803\" style=\"box-sizing:border-box;font-size:1em;line-height:1\">\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9804\" style=\"box-sizing:border-box\">\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9805\" style=\"box-sizing: border-box; border: medium none; margin-bottom: 27px; font-size: 1.6em; line-height: 1.125; text-align: justify;\">\n\t\t\t\t\t\t<sup id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9806\" style=\"box-sizing:border-box\"><a data-saferedirecturl=\"https:\/\/www.google.com\/url?hl=tr&amp;q=http:\/\/www.pharmaceutical-journal.com\/news-and-analysis\/research-briefing\/diclofenac-and-ibuprofen-linked-to-significantly-increased-risk-of-cardiac-arrest\/20202466.article%23fn_link_1&amp;source=gmail&amp;ust=1491028733470000&amp;usg=AFQjCNGR-Yv-V46RiKzTb7Hex2U3Yp193g\" href=\"http:\/\/www.pharmaceutical-journal.com\/news-and-analysis\/research-briefing\/diclofenac-and-ibuprofen-linked-to-significantly-increased-risk-of-cardiac-arrest\/20202466.article#fn_link_1\" id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9807\" style=\"box-sizing:border-box;color:rgb(0,83,133);text-decoration:none\" target=\"_blank\">[1]<\/a><\/sup>Sondergaard K, Weeke P, Wissenberg M&nbsp;<em id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9808\" style=\"box-sizing:border-box\">et al<\/em>. Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case-time-control study.&nbsp;<em id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9809\" style=\"box-sizing:border-box\">Eur Heart J Cardiovasc Pharmacother<\/em>&nbsp;2017;356:100-107.<wbr \/>&nbsp;<a data-saferedirecturl=\"https:\/\/www.google.com\/url?hl=tr&amp;q=http:\/\/dx.doi.org\/10.1093\/ehjcvp\/pvw041&amp;source=gmail&amp;ust=1491028733470000&amp;usg=AFQjCNFsCjnctmf_KYHWjdTDaoYQUFmuUw\" href=\"http:\/\/dx.doi.org\/10.1093\/ehjcvp\/pvw041\" id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9810\" style=\"box-sizing:border-box;color:rgb(0,83,133);text-decoration:none\" target=\"_blank\" title=\"Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case-time-control study\">doi: 10.1093\/ehjcvp\/pvw041<\/a>\n\t\t\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9811\" style=\"box-sizing:border-box;margin-bottom:27px;border-top:1px solid rgb(212,212,212);border-bottom:1px solid rgb(212,212,212);padding:8px 0px 10px\">\n<div dir=\"ltr\" id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9812\" style=\"box-sizing: border-box; border: medium none; font-size: 1.4em; line-height: 1.286; font-family: myriad-pro,Helvetica,Arial,sans-serif; text-align: justify;\">\n\t\t\t\t<strong id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9813\" style=\"box-sizing:border-box\">Citation:&nbsp;<\/strong><span id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9814\" style=\"box-sizing:border-box;font-style:italic\">Clinical Pharmacist<\/span><span id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9815\" style=\"box-sizing:border-box\">, Vol 9, No 4, online |&nbsp;<\/span><span id=\"m_-287756852483698803yui_3_16_0_ym19_1_1490937834256_9816\" style=\"box-sizing:border-box\">DOI: 10.1211\/CP.2017.20202466<\/span>\n\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Having studied data from nearly 30,000 patients with a history of cardiac arrest, researchers conclude that over-the-counter NSAIDs should only be available in pharmacies and at low doses and quantities. Clinical Pharmacist29 MAR 2017 &nbsp; Source: Stephen Barnes \/ Alamy Stock Photo Research published in the&nbsp;European Heart Journal: Cardiovascular Pharmacotherapy&nbsp;showed that diclofenac was linked to&#8230; <\/p>\n","protected":false},"author":1,"featured_media":742,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_links_to":"","_links_to_target":""},"categories":[9],"tags":[],"_links":{"self":[{"href":"https:\/\/infeksiyon.org\/en\/wp-json\/wp\/v2\/posts\/740"}],"collection":[{"href":"https:\/\/infeksiyon.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infeksiyon.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infeksiyon.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/infeksiyon.org\/en\/wp-json\/wp\/v2\/comments?post=740"}],"version-history":[{"count":4,"href":"https:\/\/infeksiyon.org\/en\/wp-json\/wp\/v2\/posts\/740\/revisions"}],"predecessor-version":[{"id":745,"href":"https:\/\/infeksiyon.org\/en\/wp-json\/wp\/v2\/posts\/740\/revisions\/745"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infeksiyon.org\/en\/wp-json\/wp\/v2\/media\/742"}],"wp:attachment":[{"href":"https:\/\/infeksiyon.org\/en\/wp-json\/wp\/v2\/media?parent=740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infeksiyon.org\/en\/wp-json\/wp\/v2\/categories?post=740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infeksiyon.org\/en\/wp-json\/wp\/v2\/tags?post=740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}